Roche Holding reported CHF25.22B in Loan Capital for its fiscal semester ending in June of 2026.





Loan Capital Change Date
AbbVie USD 62.48B 2.05B Jun/2026
Alcon AG USD 4.69B 41M Sep/2026
Almirall EUR 303.77M 21.04M Jun/2026
Amgen USD 51.61B 250M Sep/2026
AstraZeneca USD 28.8B 2.79B Sep/2026
Bayer EUR 37.7B 6.54B Sep/2026
Biogen USD 7.29B 1.7M Sep/2026
Bristol-Myers Squibb USD 41.85B 244M Sep/2026
Eli Lilly USD 46.99B 872M Sep/2026
Fresenius EUR 10.51B 952M Sep/2026
Fresenius Medical Care EUR 5.15B 676.78M Sep/2026
Genmab DKK 4.96B 28M Jun/2026
Gilead Sciences USD 23.82B 17M Sep/2026
GlaxoSmithKline GBP 21.7B 7.75B Sep/2026
GRIFOLS EUR 8.69B 1.52B Sep/2026
Hikma Pharmaceutical USD 1.49B 692M Dec/2025
Lakefront Biotherapeutics EUR 1.83M 2.94M Sep/2026
Lonza CHF 3.88B 323M Dec/2025
Merck EUR 10.34B 866M Sep/2026
Merck USD 49.69B 1.39B Sep/2026
Novartis USD 38.38B 893M Sep/2026
Orion EUR 103.4M 7.2M Jun/2026
Pfizer USD 60B 498M Sep/2026
Philips EUR 6.98B 669M Sep/2026
Recordati EUR 1.57B 123.2M Sep/2026
Regeneron Pharmaceuticals USD 1.99B 400K Sep/2026
Roche Holding CHF 25.22B 2.21B Jun/2026
Sanofi EUR 16.28B 1.63B Sep/2026
UCB EUR 2.18B 634M Dec/2025